September 23, 2017August 24, 2022
VIMPAT Receives EU Approval for Expanded Pediatric Use
News
The European Commission has approved the expansion of the use of UCB’s VIMPAT (lacosamide) to include monotherapy and adjunctive therapy of partial-onset (focal) ... Read more
July 24, 2017
Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs
News
Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs). ... Read more
July 21, 2017July 21, 2017
Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say
News
Doctors have several anti-seizure options to treat epilepsy, but little data exists to show which of these treatments is best ... Read more
July 19, 2017July 19, 2017
EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women
News
The European Medicines Agency has scheduled an unprecedented public hearing in September on whether epilepsy therapies that contain sodium valproate pose a risk to pregnant ... Read more
July 17, 2017
MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says
News
A technique called MRI-guided laser interstitial thermal therapy (MgLiTT) may be a potential treatment for epilepsy patients, according to a ... Read more
July 14, 2017
Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes
News
The National Institutes of Health has awarded a $3.4 million grant to a Cleveland Clinic-led research collaboration whose objective is to come ... Read more
July 12, 2017July 17, 2017
Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds
News
Researchers studied the medical records of patients with drug-resistant focal epilepsy who underwent surgery for the disorder at the age of ... Read more
July 10, 2017July 10, 2017
Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records
News
An ultra-marathon cyclist with epilepsy has broken world indoor-track records for the longest distances covered in six and eight hours. Katie ... Read more
July 5, 2017
LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children
News
The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial onset ... Read more
June 30, 2017June 30, 2017
Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates
News
The epilepsy therapy known as Zebinix in Europe and Aptiom in the United States does not impair cognition in children, ... Read more
June 28, 2017June 28, 2017
Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows
News
Almost half of epilepsy patients surveyed in a British poll say they’ve forgotten to take their medications at least once ... Read more
June 26, 2017June 26, 2017
LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans
News
The U.S. Food and Drug Administration has granted expanded approval to LivaNova’s VNS Therapy Systems for people with drug-resistant epilepsy that allows ... Read more

April 24, 2017

Cannabis Media Group Promotes RSHO-X Cannabidiol Oil for Epilepsy

News

The medical cannabis product cannabidiol oil — marketed as RSHO-X — is showing promise as an epilepsy treatment, according to CFN Media Group. The digital media network, dedicated to legal ... Read more

April 21, 2017

Zika Virus May Trigger Epilepsy, CDC Researchers Caution in Report

News

In addition to its well-known links to birth defects, Zika virus infection during pregnancy can cause epilepsy, according to a report from the U.S. Centers for Disease Control and Prevention ... Read more

April 19, 2017April 19, 2017

GW’s Cannabinoid Therapy Epidiolex Shows Promise in Treating Children with Lennox-Gastaut Syndrome

News

Children with Lennox-Gastaut syndrome (LGS) who were treated with the cannabinoid product Epidiolex (cannabidiol) had fewer drop seizures, according to results of a clinical trial developed by Britain’s GW Pharmaceuticals. The Phase 3 ... Read more

April 17, 2017

Eisai Presentation to Include Possible Use of Epilepsy Therapy Fycompa in Children

News

Eisai Inc. will make a presentation in Boston this month on its epilepsy treatment Fycompa CIII‘s effectiveness against a range of seizure types. Company researchers involved in the presentation at the annual meeting of the ... Read more

April 12, 2017

Ganaxolone Inhibits Neural Processes in Brain Linked to Seizures, Trial Shows

News

Marinus Pharmaceuticals’ ganaxolone inhibited neural processes in the brain that, when unchecked, can trigger epileptic seizures, according to a Phase 1 clinical trial. The results suggest ganaxolone could become a ... Read more

April 10, 2017

Q-State and UCB Partnering on Precision Genetic Therapies for Epilepsy

News

Q-State Biosciences (Q-State) and UCB have agreed to work together on precision genetic therapies for epilepsy, particularly children forms that can be very severe. The collaboration will cover research costs, preclinical ... Read more

April 7, 2017

Researchers Working on Non-Invasive Method to Suppress Epileptic Seizures

News

Researchers at Carnegie Mellon University have developed a new device that detects ongoing epileptic seizures and suppresses them as they start, according to a recent study. This approach may evolve into a ... Read more

April 5, 2017

Europe Grants Orphan Drug Status to Epidiolex to Treat Severe Form of Children’s Epilepsy

News

The European Union has granted orphan drug status to the cannabinoid therapy Epidiolex to treat Lennox-Gestaut syndrome (LGS), a treatment-resistant, childhood-onset form of epilepsy. Epidiolex, GW Pharmaceuticals‘ lead cannabinoid (CBD) product candidate, is a proprietary ... Read more

April 3, 2017April 3, 2017

First Epilepsy Clinical Trial Patients Implanted with Dose-delivering Prometra II Device

News

The first refractory epilepsy patients have been implanted with Prometra II programmable infusion pumps for a clinical trial of the dose-delivery devices, according to the product’s developers, Flowonix Medical and Cerebral Therapeutics. Dan ... Read more

March 31, 2017

Cannabis Product Reduces Epileptic Seizures in Lennox-Gastaut Syndrome, Study Shows

News

A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The study ... Read more

March 29, 2017March 29, 2017

Zynerba Completes Enrollment for Two Phase 2 Trials of ZYN002 for Epilepsy and Osteoarthritis

News

Zynerba Pharmaceuticals has completed enrollment in two Phase 2 clinical trials evaluating ZYN002 cannabidiol (CBD) gel in adults with epilepsy and osteoarthritis. Cannabidiol is a non-psychoactive cannabinoid. Naturally occurring cannabinoids ... Read more

March 27, 2017March 27, 2017

Myelin Loss May Trigger Epileptic Seizures in MS, Mouse Study Suggests

News

Scientists at the University of California-Riverside think they know why patients with multiple sclerosis (MS) are up to six times more likely to suffer from epilepsy. The newfound link may lead to the ... Read more

VIMPAT Receives EU Approval for Expanded Pediatric Use

Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs

Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say

EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women

MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says

Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes

Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds

Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records

LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children

Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates

Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows

LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans